Cheryl Cohen Insider Trading $NK ImmunityBio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Cheryl Cohen.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Cheryl Cohen. Cheryl Cohen is Director in CYTRX CORP ($CYTR) and Chief Commercial Officer in MEDIVATION, INC. ($MDVN) and Director in MEI Pharma, Inc. ($MEIP) and Director in VITAL THERAPIES INC ($VTL) and Director in NantKwest, Inc. ($NK) and in Tokai Pharmaceuticals Inc ($TKAI) and Director in Tokai Pharmaceuticals Inc ($TKAI) and Director in Aerpio Pharmaceuticals, Inc. ($ARPO).

Cheryl Cohen in ImmunityBio, Inc.

Trading Symbol: NK
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Cheryl Cohen: Director
Holdings: 270,925 shares
Current Value: $1,384,427
Latest Transaction: Aug 13 2020
$NK Market Capitalization: $425.06M
$NK Previous Close: $5.11

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Cheryl Cohen in ImmunityBio, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARPO, CYTR, ELDN, VTL, NK, MDVN, MEIP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 13 2020NKNantKwest, Inc.Cohen CherylDirectorSellS9.9630,000298,785270,925300.9 K to 270.9 K (-9.97 %)
Jun 11 2020NKNantKwest, Inc.Cohen CherylDirectorOption ExerciseA6.21100,000621,000100,000
Jun 07 2019NKNantKwest, Inc.Cohen CherylDirectorGrantA0.00300,9250300,9250 to 300.9 K
Jun 07 2019NKNantKwest, Inc.Cohen CherylDirectorGrantA0.00300,9250300,9250 to 300.9 K

Page:   1